Pneumococcal Vaccination Atlas

Country Profile: France

VIEW ATLAS

Recommendations

Children:
Children aged 2 to 11 months​

At-risk groups:
At-risk groups over the age of 5 with increased risk of invasive pneumococcal disease

Older adults:
No recommendation

Coverage figures

Children: 91.80% (2021)

At-risk groups: 6.00%* (2016)

Older adults: –

Vaccination advisory body/committee

Technical Committee on Vaccination (Commission technique des vaccinations)

Visit website

 

Notes:

*Figure taken from Ipsos Healthcare survey based on interviews with 1001 people aged 50 years and over.

DOWNLOAD DATA

Sources:

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=76

Children

WHO: https://immunizationdata.who.int/pages/coverage/pcv.html?CODE=FRA&ANTIGEN=PCV1+PCV2+PCV3&YEAR=

At-risk groups

Ipsos: https://www.ipsos.com/sites/default/files/migrations/en-uk/files/Assets/Docs/Publications/ipsos-healthcare-pneu-vue-report-france.pdf

Children

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=76

At-risk groups

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=76

Report an issue: Something doesn’t look right? Contact us